Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.35 | N/A | -1.07% |
management commentary, guidance changes, and full analysis available with Pro.
| -1.07% |
Tone: Cautiously Optimistic
Management expressed a cautious optimism regarding future growth despite current market challenges. They emphasized their commitment to innovation and strategic investments.
Management highlighted ongoing investments in innovation.
They noted challenges in certain markets but remain focused on long-term growth.
Boston Scientific's earnings report showed a slight miss on EPS, which contributed to a 0.97% decline in stock price. The lack of revenue data and guidance may have raised concerns among investors. Management's cautious tone reflects ongoing challenges but a commitment to future growth through innovation.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KONINKLIJKE PHILIPS ADR
Oct 22, 2018